Genital Lichen Sclerosus is a chronic inflammatory vulva disease, therefore primarily affects the external female genital organs. More rarely other body areas are also affected, and men (Phimosis) and even children can be afflicted with Lichen Sclerosus.
Women are however affected by the so-called dry lichen four times more frequently than men, children only in exceptional cases. The skin disease is associated with extremely unpleasant itching that occurs in bouts. With advancement it comes to atrophy of the upper skin layers, meaning thinning of the skin, which is usually painful. According to current understanding Lichen Sclerosus is an autoimmune disease.
Classically cortico-steroids as well as active substances from the group of the calcineurin inhibitors are used for therapy, which act as immune-suppressants, meaning they suppress the immune system, and are accompanied by adverse reactions.
During the bout-free intervals, however, the local care plays a decisive role. An application observation of the skin clinic Darmstadt showed promising results of an accompanying therapy with animal-free thymus peptides: in more than 76% of the cases Thymuskin Sclero discrete showed a decrease of itching, burning and also sclerosis. Bout-free intervals were therefore able to be extended. Local adverse reactions were not observed.
The DERMATEST seal distinguishes the Thymuskin Sclero discrete Cream as optimum skin care for the intimate area with genital Lichen Sclerosus of women and men (Phimosis). The product is free from parabens, coloring agents, perfume and any animal ingredients.